Table of Contents Author Guidelines Submit a Manuscript
Autoimmune Diseases
Volume 2015, Article ID 751853, 5 pages
http://dx.doi.org/10.1155/2015/751853
Research Article

Predisposition to Cervical Atypia in Systemic Lupus Erythematosus: A Clinical and Cytopathological Study

1Rheumatology and Rehabilitation Department, Faculty of Medicine, Cairo University, Cairo, Egypt
2Pathology Department, National Cancer Institute (NCI), Cairo University, Cairo, Egypt
3Gynecology and Obstetrics Department, Faculty of Medicine, Cairo University, Cairo, Egypt

Received 28 November 2014; Accepted 26 January 2015

Academic Editor: Yehuda Shoenfeld

Copyright © 2015 Hend Hilal Al-Sherbeni et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Cibere, J. Sibley, and M. Haga, “Systemic lupus Erythematosus,” Rheumatology, vol. 48, no. 10, pp. 1222–1226, 2009. View at Publisher · View at Google Scholar
  2. X. W. Jin, J. Cash, and A. W. Kennedy, “Human papillomavirus typing and the reduction of cervical cancer risk,” Cleveland Clinic Journal of Medicine, vol. 66, no. 9, pp. 533–539, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. C. D. Harro, Y.-Y. S. Pang, R. B. S. Roden et al., “Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine,” Journal of the National Cancer Institute, vol. 93, no. 4, pp. 284–292, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. E. L. Franco, “Cancer causes revisited: human papillomavirus and cervical neoplasia,” Journal of the National Cancer Institute, vol. 87, no. 11, pp. 779–780, 1995. View at Publisher · View at Google Scholar · View at Scopus
  5. J. M. M. Walboomers, M. V. Jacobs, M. M. Manos et al., “Human papillomavirus is a necessary cause of invasive cervical cancer worldwide,” The Journal of Pathology, vol. 189, no. 1, pp. 12–19, 1999. View at Google Scholar
  6. P. Holowaty, A. B. Miller, T. Rohan, and T. To, “Natural history of dysplasia of the uterine cervix,” Journal of the National Cancer Institute, vol. 91, no. 3, pp. 252–258, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. G. N. Papanicolaou, “A survey of the actualities and potentialities of exfoliative cytology in cancer diagnosis,” Annals of internal medicine, vol. 31, no. 4, pp. 661–674, 1949. View at Publisher · View at Google Scholar · View at Scopus
  8. R. J. Kurman, D. E. Henson, A. L. Herbst, K. L. Noller, and M. H. Schiffman, “Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Workshop,” The Journal of the American Medical Association, vol. 271, no. 23, pp. 1866–1869, 1994. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Kriss, L. Kovasc, and P. Szodoray, “Malignancies in systemic lupus erythematosus,” Autoimmunity Reviews, vol. 9, no. 4, pp. 195–199, 2010. View at Google Scholar
  10. M. Ciołkiewicz, I. Domysławska, A. Ciołkiewicz, P. A. Klimiuk, and A. Kuryliszyn-Moskal, “Coexistence of systemic sclerosis, scleroderma-like syndromes and neoplastic diseases,” Polskie Archiwum Medycyny Wewnetrznej, vol. 118, no. 3, pp. 119–126, 2008. View at Google Scholar · View at Scopus
  11. R. Nath, C. Mant, J. Luxton et al., “High risk of human papillomavirus type 16 infections and of development of squamous intraepithelial lesions in systemic lupus erythematosus patients,” Arthritis & Rheumatism, vol. 57, no. 4, pp. 619–625, 2007. View at Google Scholar
  12. M. C. Hochberg, “Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus,” Arthritis and rheumatism, vol. 40, no. 9, p. 1725, 1997. View at Google Scholar · View at Scopus
  13. A. Vince and S. Z. Lepej, “Diagnostic methods and techniques in cervical cancer prevention part II: molecular diagnostics of HPV infection,” Medicinski Glasnik, vol. 7, no. 1, pp. 18–25, 2010. View at Google Scholar
  14. N. Behtash and N. Mehrdad, “Cervical cancer: screening and prevention,” Asian Pacific Journal of Cancer Prevention, vol. 7, no. 4, pp. 683–686, 2006. View at Google Scholar · View at Scopus
  15. H. Esmaeili and K. Ghahremanzadeh, “Association of pap smear abnormalities with autoimmune disorders,” Pakistan Journal of Biological Sciences, vol. 14, no. 10, pp. 600–604, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Nath, C. Mant, J. Luxton et al., “High risk of human papillomavirus type 16 infections and of development of cervical squamous intraepithelial lesions in systemic lupus erythematosus patients,” Arthritis Care and Research, vol. 57, no. 4, pp. 619–625, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Bateman, Y. Yazici, L. Leff, M. Peterson, and S. A. Paget, “Increased cervical dysplasia in intravenous cyclophosphamide-treated patients with SLE: a preliminary study,” Lupus, vol. 9, no. 7, pp. 542–544, 2000. View at Publisher · View at Google Scholar · View at Scopus